Cocrystal Pharma, Inc.
USD1.03
+0.01 (+0.49%)
CEO
Sam Lee
IPO Date
2012-02-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.00
Prev. Close
$1.03
Day Low
$1.00
Day High
$1.04
52W Low
$0.86
52W High
$2.67
Market Cap
$0.01B
Volume
0.00M
| -1.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -68.2% | -57.5% | 0.07 | 8.92 | -0.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -98.2% | -95.1% | 0.01 | 33.04 | -0.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -18.3% | -17.9% | 0.01 | 38.40 | -4.2 |
| 31 Dec 2020 | FY | -199.6% | -479.0% | -18.4% | -17.8% | 0.01 | 25.05 | -8.1 |
| 31 Dec 2019 | FY | 39.0% | -733.8% | -187.4% | -168.8% | 0.03 | 3.62 | -0.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -73.3% | -71.5% | 0.00 | 1.89 | -2.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -0.6% | -0.5% | 0.01 | 1.55 | -236.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -73.2% | -60.0% | 0.00 | 2.68 | -3.7 |
| -1.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -26.7% | -19.6% | 0.21 | 5.78 | -1.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -38.5% | -24.2% | 0.31 | 3.69 | -1.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -31.5% | -21.6% | 0.24 | 4.57 | -1.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -34.3% | -24.3% | 0.19 | 4.77 | -1.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -38.9% | -30.4% | 0.15 | 7.32 | -0.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -30.7% | -24.8% | 0.10 | 7.41 | -1.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -17.5% | -14.9% | 0.08 | 10.30 | -1.0 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -16.9% | -14.3% | 0.07 | 8.92 | -1.0 |